B-Catenin, transcription factor of Wnt signaling, is promoted in patients with intervertebral disc (IVD) degeneration, but Wnt signaling decreases with aging. We hypothesize that IVD degeneration is associated with decreased Wnt signaling despite more b-Catenin. Chronic compression of tail IVDs of young-adult and aged Wnt-reporter (TOPGAL) animals initiated an age-related cascade of degenerative-like changes, which included reduced Wnt ligand expression and Wnt signaling in nucleus pulposus cells, despite elevation of b-Catenin protein and gene expression. To determine the effect of upregulated and downregulated Wnt signaling in adult discs, b-Catenin in the nucleus pulposus was stabilized (Shh-CreEr T2 /b-Catenin fl(Ex3)/fl(Ex3) , cACT) or knocked out (Shh-CreEr T2 /b-Catenin fl/fl , cKO). cACT discs had promoted expression of Wnt-targets and -ligands, brachyury, extracellular matrix production and 34% greater compressive stiffness than WT (b-Catenin fl(Ex3)/fl(Ex3) ) discs, but 50% less tensile stiffness. By contrast, knockout reversed the cACT phenotype: less protein expression of b-catenin in the nucleus pulposus, less expression of brachyury, heightened expression of extracellular matrix breakdown and 46% less compressive stiffness than wild-type (b-Catenin fl/fl ,WT) discs. These data suggest that intervertebral disc degeneration is associated with loss of Wnt signaling and that the concomitant increase in b-catenin is a regenerative response, potentially offering a therapeutic approach to degeneration.
Transcription factor b-Catenin (bCAT) is regulated by the canonical Wnt pathway 16 and is putatively involved in the catabolism of IVDs. In brief, if negative regulators secreted frizzled-related proteins (sFRP) and SOST/DKK do not bind to Wnt and LRP5 or 6, respectively, Wnt ligands bind to Low-density lipoprotein receptor-related protein 5/6 (LRP5/6) receptors and Frizzled co-receptors. Once activated, the tail end of the complex inhibits glycogen synthase kinase (GSK) and allows the stabilization of b-Catenin, which may then translocate to the nucleus, interact with T-Cell factor/lymphoid enhancer factor (TCF/LEF) and initiate gene transcription. Both patients with IVD degeneration and canines with an age-related propensity for degeneration have up-regulated levels of b-Catenin 17, 18 . In vitro, Wnt signaling and greater b-Catenin in rodent IVD cells may trigger cellular senescence, apoptosis and biomarkers of matrix breakdown 19 . Further, brachyury T is a transcription factor for notochordal cells and requires TCF/LEF signaling 20 . Notochordal cell fate is driven by Wnt signaling activity 21 and, T expression decreases in canines with an age-related propensity for intervertebral disc degeneration 22 , which is consistent with an age-related loss of Wnt signaling 21, 23, 24 . In mice, constitutive activation of b-Catenin in the cells of the annulus fibrosus leads to IVD degradation by increasing biomarkers of matrix breakdown 17 . By contrast, Wnt signaling decreases with aging, with concentrated decreases in the NP 23 . Disrupting Wnt signaling and b-Catenin during development deteriorates the entire IVD 24, 25 . Therefore, the aim here was to clarify the early changes in canonical Wnt signaling and b-catenin during IVD degeneration and the role of altering b-catenin in the NP and not the annulus fibrosus.
The approach applied here is the first known instance of the determination of Wnt signaling/b-Catenin in an in vivo model of murine intervertebral disc degeneration and of the exclusive regulation of Wnt/b-Catenin signaling in the NP, a hallmark location for the beginning of IVD degeneration. We hypothesize that IVD degeneration is associated with reduced Wnt signaling despite the upregulation of b-Catenin, which can be a regenerative response. Here, we apply in vivo chronic loads to adult tail IVD of transgenic mice designed to report Wnt activity. Next, b-Catenin was constitutively activated (cACT) in Sonic hedgehog (Shh)-expressing cells of the NP that resist degradation to demonstrate the in vivo consequences of greater b-Catenin, which appear in degenerated IVDs. Further, transcription factor b-Catenin was suppressed in Shh-expressing cells and consequences noted after 1 or 3 months. Lastly, the tail intervertebral discs of b-Catenin gain-of-function mice were subjected to static compression to determine the effect of regulating b-Catenin in a model of disc degeneration to offer insight to potential therapeutics and caveats.
Results
In Vivo Caudal (Tail) Compression Induced Intervertebral Disc Degenerative Changes. First, we aimed to determine whether aging would enhance degeneration during tail compression because it is know that Wnt signaling declines with aging 21, 23 . We previously demonstrated that aging-related changes of tail IVD from 5 to 12 months (mo) of age model human aging: increased stiffness and collagen content, and loss of proteoglycan content 23 . Therefore, IVDs of Wnt-reporter TOPGAL mice aged 5 and 12 mo old were instrumented at vertebrae CC7 and CC9 (Fig. 1A,B ), compressed to a force of 2.25 N (1.3 MPa). Tails compressed for 1 week and harvested 3 weeks later to propagate IVD degeneration 9 demonstrated features of IVD degeneration by disorganization in the NP and fissures in the annulus fibrosus ( Fig. 1C ). After 1 week of static compression, loading altered gene expression in 5 mo and 12 mo mice, but with some greater changes in older mice (Fig. 1C ). In 5 mo IVDs, loading reduced Col2A and increased matrix metalloproteinase (MMP)13 gene expression. Middle-aged (12 mo) IVD had greater changes than 5 mo IVD. Aggrecan turnover (Aggrecan and Adamts5) increased by 5-fold and catabolic gene expression of Adamts5 and MMP13 were greater in 12 mo IVDs than 5 mo IVDs. Osteogenic marker Osterix (Osx a.k.a. Sp7) declined with loading in 5 mo IVDs by 60% and in 12 mo IVDs by 50% ( Fig. 1C ).
Tail Compression Reduced Wnt/b-Catenin Signaling in the Nucleus Pulposus Despite
Greater b-Catenin. Next, we aimed to address the apparent disparity between the loss of Wnt signaling from aging-related IVD degeneration in mice 21, 23 and the increase in the Wnt signaling transcription factor b-Catenin in patients with IVD degeneration 17 . In 5 mo and 12 mo IVD, loading reduced notochordal marker Brachyury (T) expression ( Fig. 1C ), which is indicative of reduced Wnt signaling 26 . Corroborative with T expression, compression in 5 mo IVD suppressed Wnt ligands; out of 19 Wnt ligands, 13 were detectable and 3 (Wnt 16, 10a and 2b) declined with compression ( Fig. 2B ). In 12 mo IVD, 5 were detectable (Wnt 16, 5b, 10b, 5a and 11) and Wnt10b declined with aging (data not shown).
Next, we determined the Wnt activity in a reporter of Wnt signaling (TOPGAL) 27 , the expression of b-Catenin and of targets of Wnt signaling 28, 29 , and the expression of elements proposed to regulate b-Catenin translocation into the nucleus pulposus 30 . TOPGAL mice were instrumented and the IVDs between the pins were either compressed (Loaded) or not compressed (Sham). LacZ staining in control IVDs showed blue staining in the NP, which was representative of Wnt signaling and loading decreased Wnt signaling in 5 mo and 12 mo IVDs, but was severely ablated in 12 mo IVD ( Fig. 2C ). 5 mo and 12 mo IVDs that were compressed (CC7-9) had 80% and 60% less Wnt-activity in the NP than the internal age-matched control IVDs (CC10-12), respectively ( Fig. 2C ,D, Table S1 ). Sham animals had no change in Wnt-activity from instrumentation. However, compression in both ages of mice regulated gene expression of Wnt pathway markers (b-Catenin, Dkk1, and AXIN2) toward activation ( Fig. 2E ) and protein expression of b-Catenin corroborated these findings. In 5 mo old mice, a 40× magnification of the NP stained with LacZ and co-staining for b-Catenin showed more b-Catenin-positive cells in the NP without Wnt activity than the control IVD (empty arrows), and fewer (blue arrows) Wnt-positive cells ( Fig. 2F , Table S2 ). The effect was greater in 12 mo IVD, where b-Catenin positive cells were spatially separated from Wnt-active cells in the NP. Axin2 was not detectable in 12 mo IVD. Lastly, Sun1, NESP1 and NESP2, elements of the Linker of Nucleoskeleton and Cytoskeleton (LINC) complex, decline with compression and aging ( Fig. 2G In tissues other than the NP, active Wnt signaling appears in the growth plate of vertebrae from young-adult and middle-aged mice (Fig. S1 ). Puncture is a more severe model of IVD degeneration that greatly disrupts the NP and annulus fibrosus (AF), and increases Wnt signaling in the annulus fibrosus ( Fig. S2 ). Similar to the dichotomous response to tail compression in the NP, puncturing the AF increases b-Catenin protein expression without necessarily activating Wnt signaling (brown staining without blue) ( Fig. S2C ). Overall, these data suggest that greater b-Catenin protein in degenerated IVDs does not necessarily indicate greater Wnt activity, but rather that disc degeneration in the NP is associated with reduced Wnt activity despite accumulation of b-Catenin.
In Vivo Nucleus Pulposus-Specific, Constitutive Activation of b-Catenin Increased Wnt-related expression and the Compressive Stiffness of Intervertebral Discs. Lumbar and tail IVD may not
show equivalent changes to experimental treatments because they differ in biomechanics, metabolism and with aging 23, 31, 32 . Biomechanical changes to each disc level were determined and the level with greatest change in biomechanical properties was used as the deciding factor for further analysis. To mimic the accumulation of b-Catenin in the NP during tail compression and determine its contribution, we crossed b-Catenin fl(Ex3)/fl(Ex3) (WT) with Shh-CreER T2 mice to yield b-Catenin fl(Ex3)/fl(Ex3) /Shh-CreER T2 mice (bCAT cACT). bCAT cACT and WT mice were dosed daily with tamoxifen (5 d) and their IVDs were harvested 3 weeks later (Fig. 3A) . In mice expressing double-floxed alleles and a Cre-driver, excision of exon3 in b-Catenin makes b-Catenin resistant to phosphorylation 33 . First, the location of the cells expressing Shh in adult (4 mo) IVDs was determined by crossing Ai9(RCL-tdT) mice with Shh-CreER T2 (Shh-CreER T2 /tdT) and injecting them with tamoxifen for two days. tdT served as controls and showed no expression. Shh was expressed in the cells of the NP and cartilage endplate of tail IVDs (Fig. 3B ). In lumbar IVDs, expression of Shh was limited to NP cells ( Fig. 3C ). In our hands, the targeting efficiency of the Shh-CreER T2 was 34 ± 5% of the cells of the lumbar NP. More importantly, the compressive stiffness of the IVD was greater in both IVDs from both spinal levels in cACT bCAT mice than WT ( Fig. 3F ,G), but tail IVDs also lost tensile stiffness and developed proteoglycan nodules near the cartilage endplate (white arrows).
Stabilization of b-Catenin in the NP upregulated Wnt signaling-related genes towards activation and extracellular matrix-related genes toward production. Quantitative polymerase chain reaction (QPCR) of the whole IVD (NP and annulus fibrosus) corroborated the Cre-mediated excision of exon3 by the reduced expression of full-length b-Catenin mRNA expression ( Fig. 4D ), but quantification in the NP by immunohistochemistry did not reach statistical significance and no changes were noted in the annulus fibrosus ( Fig. 4B,C) . Wnt-related gene expression was highly impacted by b-Catenin stabilization; notochordal marker T increased by 50% (suggesting Wnt signaling activation) and Axin2, CCND1 and DKK1 were regulated towards activation of the pathway (Fig. 4D ). Further, Wnt ligands 16, 10b, 5a, 11 and 9a were upregulated with b-Catenin stabilization by 3-11 fold, while Wnt4 was downregulated ( Fig. 4E ). Alterations to b-Catenin expression mediated extracellular matrix-related gene; aggrecan expression increased while Adamts5 expression decreased in bCAT cACT discs compared to WT. Further changes included suppression of MMP13 expression by almost 50% and Osx expression by 27%. Taken together, stabilization of b-Catenin stiffened the IVD via anabolic and anti-catabolic changes to the constituents of the IVD.
In Vivo Nucleus Pulposus-Specific, Constitutive Activation of b-Catenin Protected the Intervertebral Disc from Tail Compression.
To further demonstrate that increased b-Catenin is a potential mechanism of protection, we compressed the tails of cACT mice and their WT group. We dosed cACT and WT mice daily with tamoxifen for 5 days and, after two days, subjected them to 1 week of tail compression ( Fig. 5A ) or harvested the IVDs to confirm recombination and suppression of wild-type b-Catenin prior to loading (Fig. 5B ). The dosing schedule was optimized to limit the changes in the biomechanics of the IVD in order to apply a comparable mechanical strain between the two groups but, at the same time, induce recombination. The number of cells expressing b-Catenin in the NP was greater in cACT than WT ( Fig. S5 ). Compression may have induced a mild increase in the number of cells positive for b-Catenin in the NP of WT mice, which may have been greater in the NP of cACT mice. Relative to the nonloaded, internal control IVDs, loading reduced the expression of b-Catenin in WT (b-Catenin fl(Ex3)/fl(Ex3) ) discs and increased b-Catenin expression in cACT IVDs (Fig. 5C ). Similarly, static chronic compression reduced aggrecan and osterix gene expression by ~60% in the IVDs of WT mice, but was unchanged in the cACT discs (+fold change of ~2). The expression of catabolic genes did not differ between the animals. Lastly, a comparison of the loaded IVDs with Safranin-O demonstrated that the cACT mice could partly protect the nucleus pulposus by maintaining the concavity of the NP, but the annulus fibrosus still presented with fibril fraying (Fig. 5D ). By and large, phosphorylation-resistant b-Catenin in the NP of cACT promoted the accumulation of b-Catenin during tail compression, which partially protected the IVD from tail compression.
In Vivo Nucleus Pulposus-Specific, Short-Term Deletion of b-Catenin Reduced the Compressive Stiffness of Lumbar Intervertebral Discs, But Minimally Affected Tail Intervertebral Discs.
In order to mimic the suppression of Wnt signaling in the NP that was inactivated by static compression, transcription factor b-Catenin was suppressed in Shh-expressing cells of the lumbar and tail IVDs and the effects of this genetic manipulation were examined without the application of exogenous loading. To suppress b-Catenin in nucleus pulposi, b-Catenin fl/fl (WT) mice were crossed with Shh-CreER T2 to yield b-Catenin fl/fl /Shh-CreER T2 mice (bCAT cKO). bCAT cKO and WT mice were injected daily with tamoxifen for 5 days, and IVDs harvested 3 weeks later for gene expression, mechanics and histology (Fig. 6A ). In the tail IVDs, no histological or biomechanical changes were noted between cKO and WT (Fig. 6B,D) . By contrast, the compressive stiffness of lumbar IVDs was 46% less in bCAT cKO than WT, consistent with depletion of proteoglycan in the NP as demonstrated by less safranin-O staining (Fig. 6C,E) .
Further analysis of lumbar IVDs showed that deletion of b-Catenin suppressed protein expression of b-Catenin in the NP by 60% ( Fig. 7B ,C, no changes were noted in the annulus fibrosus). mRNA expression of b-Catenin declined by 25% in bCAT cKO compared to WT discs (Fig. 7D ). Deletion of b-Catenin reduced Wnt signaling as noted by reduced expression of notochordal marker Brachyury, T, by 40%. Further, deletion of b-Catenin reduced expression of proliferation marker CCND1 by 18% and increased Osx by 25%. In terms of matrix-related gene expression, deletion of b-Catenin affected aggrecan homeostasis by reducing aggrecan expression by 37% and increasing Adamts5 by 74%. In contrast to the lumbar IVDs, few changes were noted 3 weeks after 1-week deletion of b-Catenin in tail IVDs (Fig. S4A) . B-Catenin protein expression was unchanged ( Fig S4B) . 1 week of tamoxifen injections did reduce b-Catenin gene expression ( Fig. S4C ), but following 3 weeks without injections, b-Catenin expression rebounded and in bCAT cKO was greater than in WT (Fig. S4D) , suggesting that tail IVD might require more doses of tamoxifen to induce a similar phenotype to lumbar IVDs. Thus, short-term deletion of b-Catenin in the NP of lumbar IVDs of adult mice reduced the compressive stiffness in association with altered matrix constituents.
In Vivo Long-Term Effects of Short-Term Deletion of b-Catenin to Lumbar Intervertebral Discs.
We next sought to determine if a longer post-deletion period of 11 weeks (Fig. S5A ) would lead to further deterioration or to recovery of the lumbar IVD in bCAT cKO mouse. Many of the consequences of short-term deletion that were observed at 3 weeks were normalized after 11 weeks, e.g., gene expression of b-Catenin was greater by 60% in bCAT cKO than WT IVDs (Fig. S5B) . Similarly, matrix-related, proliferation and osterix gene expression in 7 mo bCAT cKO IVD were greater than WT lumbar IVDs by up to 3-fold. Wnt signaling and notochordal marker T did not change. Histologically, bCAT cKO discs were saturated with proteoglycans to a similar degree as 7 mo WT discs, but the cells of the NP contracted (Fig. S5C ) unlike the expansion of the NP cells in b-Catenin activated mice (Fig. 3E) . Mechanically, the compressive stiffness of the bCAT cKO and WT IVDs were on par Fig. 6D ), due to enhanced matrix gene expression in bCAT cKO discs. However, there were residual, potentially harmful effects to the recovery of the lumbar IVD. The long-term upregulation of matrix-related genes in response to deletion of b-CAT in the NP increased the tensile (p = 0.08) and neutral zone (p < 0.05) stiffness of the IVD. Again, tail IVD were not affected in the long-term by brief deletion of b-Catenin (Fig. S6) . Overall, long-term restoration of the compressive stiffness of lumbar IVD after brief b-Catenin suppression may have been related to normalization of b-Catenin and aggrecan.
Correlations between Regulation of b-Catenin in the Nucleus Pulposus and Intervertebral Disc
Biomechanics. Despite stabilization of b-Catenin imposing a benefit to the compressive mechanical stiffness, it reduced the tensile stiffness of tail IVDs and tensile stiffness was negatively associated with the fraction of b-Catenin-expressing cells in the NP (R 2 = 0.56, p < 0.05, Fig. 8A ). ADAMTS5 expression was strongly associated with b-Catenin expression in the whole tail IVD (R 2 = 0.82, p < 0.001, Fig. 8B ). In the KO scenario in which tails were ostensibly in a regenerative mode at the time of harvest, elevated b-Catenin expression was moderately correlated with elevated aggrecan expression (R 2 = 0.59, p < 0.01, Fig. 8D ) and there was a trending relationship between the fraction of b-Catenin-positive cells of the nucleus pulposus and the compressive stiffness (R 2 = 0.53, p = 0.09, Fig. 8C ). In a similar relationship to tails of cKO IVDs, lumbar cKO IVDs had moderate-to-strong correlations between the compressive mechanics of the IVD and b-Catenin-positive cells of the nucleus pulposus (R 2 = 0.55, p < 0.05, Fig. 8E ) or b-Catenin expression of the whole lumbar IVD (R 2 = 0.74, p < 0.01, Fig. 8F ).
Discussion
A clarification of the in vivo consequences of altered Wnt signaling during intervertebral disc degeneration may offer insight into the targets for pharmacologic or non-pharmacologic therapeutics. Static compression, a model of intervertebral disc degeneration, engendered early features of IVD degeneration in adult mice. Concomitantly, TOPGAL mice demonstrated a reduction of Wnt signaling in the nucleus pulposus, a key compartment with major biological and mechanical importance to the whole IVD. However, protein and gene expression of b-Catenin increased following compression. In order to determine the role of altered Wnt/b-Catenin signaling to only the nucleus pulposus, we genetically suppressed and stabilized b-Catenin in vivo in cells expressing Shh. A consistent consequence of b-Catenin alteration was regulation of aggrecan transcription and IVD compressive stiffness, where elevated Wnt/b-Catenin signaling led to increased aggrecan expression and greater biomechanical stiffness, and suppression reversed this phenotype. Endogenous promotion of b-Catenin protected aggrecan expression and partly protected the IVD during tail compression. These data suggest that IVD degeneration is associated with a Wnt signaling-driven loss of aggrecan, and that elevating b-Catenin in the nucleus pulposus may offer protection. Tail compression is a model of IVD degeneration 9, 12 , which in its early phase is marked by loss of aggrecan to the NP and little loss to the annulus fibrosus 15 . Similar to aging of the IVD 23 , we definitively show that in vivo, early IVD degeneration by tail compression reduces Wnt signaling activity in the cells of the NP, despite increases in b-Catenin. Others have alluded to reduced Wnt signaling in degenerated IVDs 21, 22 , but have used gene or protein expression markers of Wnt signaling rather than reporters of activity. This distinction is important because transcription factor of the Wnt pathway, b-Catenin, is reported to accumulate in the IVD of patients 17 and canines 18 with IVD degeneration.
Here, b-Catenin accumulates in the IVD of tails compressed to induce intervertebral disc degeneration and we demonstrated that stabilized b-Catenin in an NP-specific manner promotes the production of the extracellular matrix and a greater compressive stiffness of the IVD. Similarly, reactivation of Wnt signaling increases aggrecan production 21 and this regenerative effect may have occurred in bCAT cKO IVD after 3 mo, but with some caveats. For instance, the long-term response of brief deficiency of b-Catenin upregulated collagen-related genes, as occurs with aging 23 and degeneration 15 , and stiffened the mechanical neutral zone of the IVD, which is associated with IVD degeneration 34 . While the accumulation of b-Catenin can normalize the IVD following brief b-Catenin-deficiency or attempts to normalize the IVD during early IVD degeneration, prolonged accumulation as noted in human degenerated annulus fibrosi can become harmful to the entire IVD 17, 24 . On the other hand, NP-specific suppression of b-Catenin reduced the compressive stiffness of the IVD, but with few overt effects to the overall appearance and structure. Similarly, Col2-mediated deletion of b-Catenin from conception targets the annulus fibrosus and imposes minor detrimental effects 24 . These data suggested that the elevated b-Catenin may have been a regenerative response to IVD degeneration and prevented excessive inactivation of Wnt signaling. Following the benefit noted in the biomechanics of IVDs from short-term upregulation of b-Catenin, we subjected the tails of 4 mo old bCAT cACT and WT mice to tail compression in order to test its potentially protective effects. Stabilization of b-Catenin was noted by an elevated percentage of b-Catenin-positive cells with and without loading. In WT mice, tail compression induced a dramatic loss of wild-type b-Catenin gene expression and aggrecan expression, and doubled the expression of ADAMTS5. By contrast, endogenous stabilization of b-Catenin plus tail compression increased b-Catenin expression and prevented the loss of aggrecan expression. Greater aggrecan may have protected the reversal of the lamellae of the annulus fibrosus into the nucleus pulposus, a metric of the scoring for the degeneration of the IVD 35 , by increasing the osmotic pressure via greater proteoglycan 36 . However, ADAMTS5 upregulation was not attenuated with increased b-Catenin and neither was the fraying of the annulus fibrosus with tail compression. Overall, promoting b-Catenin signaling may have protective qualities during IVD degeneration and suggests that therapeutics that aim to increase Wnt signaling systemically 37 , e.g., romosozumab or blosozumab, may be beneficial to the IVD.
The mechanism underlying the ineffective activation of Wnt signaling in IVD with elevated b-Catenin in response to tail compression is unclear, but may be related to impaired translocation of b-Catenin to the cell nucleus. The Linker of Nucleoskeleton and Cytoskeleton (LINC) complex is a mechanotransductive pathway proposed to be involved in b-Catenin-driven transcription in the cell nucleus 38 . Differentiation of mesenchymal stem cells to a chondro/osteogenic fate requires Wnt/β-catenin signaling 39 and, in response to mechanical loading, differentiation is abrogated in LINC-complex-deficient cells 40 . Cells deficient of LINC elements accumulate b-Catenin in the perinuclear wall and do not translocate b-Catenin to the cell nucleus 30 . In corroboration with less Wnt signaling in aged mice 23 , here, Sun1, Nesp1 and Nesp2 declined with aging and tail compression, suggesting that aged and loaded IVD were less equipped to translocate b-Catenin to the cell nucleus and that elevating b-Catenin may normalize the disruption of the LINC/b-Catenin relationship.
Concomitantly, notochordal cell expression (T) and osterix were differentially regulated by Wnt signaling in the NP. Notochordal cells of the NP are closely associated with a healthy IVD 41 , they persist in human IVDs with aging and degeneration 42 and their loss may contribute to degeneration. Corroborative of other studies 43 , tail compression suppresses the expression of notochordal cell marker T but we newly demonstrated that T expression can be modulated by endogenous regulation of b-Catenin in nucleus pulposus cells. In both the lumbar and tail IVDs, stabilization of b-Catenin in the cells of the nucleus pulposus increased the number of vacuolated cells, reminiscent of healthy, immature notochordal NP cells 44 . In relation to osterix, modulation of b-Catenin differentially influenced osterix and T expression, i.e., loss of b-Catenin downregulated T expression and upregulated osterix expression and vice versa. Osterix is a critical transcription factor in stem cell differentiation, where loss of osterix 45 or loss of b-catenin 46, 47 diverts differentiation from osteoblasts to chondrocytes, but is needed for hypertrophic differentiation 48 . The role of osterix during intervertebral disc degeneration is not well understood but our findings suggest a relationship where its regulation may contribute to the vastly different expression profiles of notochordal and chondrocytic-like cells 22 . Nucleus pulposus-specific genetic manipulation of the Wnt/b-Catenin pathway regulated the biomechanics of the IVD, potentially by mediating the differentiation and/or proliferation of resident progenitors in the nucleus pulposus.
There were a few limitations in the study. (1) All of the gene expression in the study was conducted in whole intervertebral discs which diluted the alterations of the NP, but many outcomes were determined that were specific to the NP. For instance: (i) Brachyury T is a NP specific marker in mice and humans 42, 49 that was regulated in our studies by compression, Shh-driven b-Catenin-deficiency and b-Catenin stabilization; (ii) Deletion of b-Catenin protein expression in the cKO animal studies was regulated in the NP; and (iii) Suppression and upregulation of b-Catenin expression in the NP was highly correlated to the mechanics of the entire IVD. Further, b-Catenin expression of the whole IVD and of the NP were similarly correlated to the compressive stiffness of the cKO lumbar IVDS. Nonetheless, this limitation must be kept in mind and detailed interpretations must be applied cautiously. (2) There was a lack of biomechanical change in the tails of cKO IVDs and we suggest that a prolonged suppression of Wnt signaling may be necessary to alter the functional impact. While lumbar IVD are more comparable to human IVD than tails 31 and differ from tail IVD in mechanics, metabolism and change differently with aging 23, 31, 32 , we studied tail IVDs because they have the advantage of their ease of access for manipulation. Our data suggest that b-catenin levels may have been normalized in tail IVDs after a short period of tamoxifen. Lumbar IVDs demonstrated a similar recovery effect, but over a longer period (3 mo). (3) There were a few disparities in the effect of tail compression between the WT mice and TOPGAL mice, e.g., downregulation of aggrecan and b-catenin gene expression in WT IVDs versus no effect in the 5 mo IVDs in TOPGAL mice. The applied force was the same between the mouse strains, but the size of the WT IVD was smaller and therefore, the applied stress was larger in and more harmful to the WT discs than TOPGAL discs.
In conclusion, early intervertebral disc degeneration by tail compression reduced Wnt signaling, but concomitantly increased b-Catenin with minimal Wnt activation. The mechanism was unclear, but it may have included disruption of the LINC complex, which may limit translocation of b-Catenin into the cell nucleus. Upregulation of b-Catenin and downregulation of Wnt activity in the nucleus pulposus was modeled by stabilization and deletion of b-Catenin in Shh-expressing cells, respectively. Deficiency of b-Catenin reduced the compressive stiffness of the intervertebral disc. By contrast, stabilized b-Catenin increased the compressive stiffness of the intervertebral disc and prevented compression-induced loss of aggrecan expression, albeit with some consequences. Overall, stimulating Wnt/b-Catenin signaling may be a therapeutic approach to intervertebral disc degeneration but will have to be approached with caution.
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Methods
Mice. Female TOPGAL (TCF/LEF Optimal Promoter/Galactosidase reporter) transgenic mice (Tg[Tcf-Lef1-lacZ]34Efu/J, stock # 004623, The Jackson Laboratory, Bar Harbor, ME) were inbred to bear experimental mice that were aged to 5 (n = 19) or 12 months (n = 16). The homozygous TOPGAL mice on a CD-1 background were genotyped as previously published 6 , contained the LacZ transgene under the control of the TCF/LEF promotor 27 , and were used to assay Wnt activity. Shh-CreER T2 mice (B6.129S6-Shh tm2(cre/ERT2)Cjt /J, stock # 005623) and b-Catenin fl/fl mice (B6.129-Ctnnb1 tm2Kem /KnwJ, stock # 004152) were purchased from The Jackson laboratory. To suppress b-Catenin in nucleus pulposi, b-Catenin fl/fl (WT, n = 24) mice were crossed with Shh-CreER T2 to yield b-Catenin fl/fl /Shh-CreER T2 mice (bCAT cKO, n = 32). Shh is expressed in the NP of embryonic and postnatal IVDs 50 , is required for the formation of the notochord sheath and patterning of the NP 51 , and is accepted as a marker of NP cells up to 19 months of age 49, 52 . To induce activation of b-Catenin in nucleus pulposi, b-Cateninfl(Ex3)/fl(Ex3) (WT, n = 15) were crossed with Shh-CreER T2 to yield Shh-CreER T2 /b-Catenin fl(Ex3)/fl(Ex3) mice (bCAT cACT, n = 13). Dr. Roberta Faccio generously donated the β-Catenin fl(Ex3)/fl(Ex3) mice 53 . In order to report expression of Shh in adult intervertebral discs, Ai9(RCL-tdT) mice were crossed with Shh-CreER T2 to generate the experimental Shh-CreER T2 /tdT mice. Shh-CreER T2 /tdT mice were injected with tamoxifen for two days and the IVDs harvested on the third day. tdT mice (No Cre) served as controls. Three mice were used to determine the targeting efficiency in the lumbar and 2 in the tail. The experimental design is listed in Table 1 . All mice were housed 4-5 per cage under standard conditions with ad libitum access to water and regular chow (Purina 5053 & 5058, Purina, St. Louis, MO). The animal work in this study is in compliance with all applicable agency policies. The study was approved by the Washington University Animal Studies Committee.
Tail Compression.
Once the C7 and C9 vertebra were identified with preoperative radiographs (Fig. 1B) , 23-G needles were implanted transcutaneously during anesthesia by isoflurane (2.5% vol) and postoperative radiographs confirmed proper placement. Compression rings were attached to the pins to apply mechanical load via tightening of four screws with compressive springs (Cat # 9001T24, McMaster, Elmhurst, IL). Following injection with Buprenorphine (1 mg/kg s.c.) for pain relief, 2.25 N of load was applied for 1 week to induce loss of disc height 10 and degeneration 12 . Tail puncture is another model of severe IVD degeneration 54 and was applied to 5 mo and 12 mo animals to determine the effect.
Mechanical Testing. Controlled mechanical tests were performed on L6-S1 and CC6-CC7 motion segments as previously described 6 . Prior to mechanical testing, the bone-disc-bone segments were excised, zygapophysial joints and superficial tissue were removed, and spinal units were hydrated in 1X PBS for 18 h at 4 °C. Superior and inferior vertebra were gripped by microvises and, once secured, the sample was immersed in 1X PBS. A materials testing system (Electropulse 1000, Instron, Norwood, MA, USA) applied a load range of −1.2 Newtons (N) to 0.6 N for twenty compression-tension cycles at a frequency of 0.5 Hz, respectively.
Mechanical Data Analysis of Discs. The trilinear fit model determined the compressive, tensile and neutral zone stiffness of the motion segment 6 . Briefly, the compressive and tensile loading curves were isolated and a 6 th order polynomial was fit to the 20 th loading and unloading tension-compression cycle. The minimum derivative of the curve represented the neutral zone stiffness and the derivative measured at 80% of the maximum load magnitude in the compressive and tensile portion of the curve constituted the compressive and tensile stiffness, respectively.
Histology, Immunohistochemistry and Frozen Sectioning. Beta-galactosidase staining for Wnt activity, Safranin-O, and IHC was performed as previously described 23,55 on coccygeal (CC7-CC12) motion segments. Motion segments from TOPGAL mice were freshly harvested, fixed in 4% paraformaldehyde for 1 h, incubated in Xgal (Invitrogen, Grand Island, NY) for 48 h, fixed overnight, decalcified in Immunocal for two days and embedded in paraffin using routine methods. These, coronal sections (10 µm) were used to visualize galactosidase cells and serial sections were counter stained with eosin or Safranin-O. All other intervertebral discs from other mice were not incubated with Xgal or fixed overnight. Sections for immunohistochemistry were deparaffinized and stained with total β-catenin antibody (targets nuclear and cytoplasmic beta-catenin, tail compressed: n = 1/age, disc puncture: n = 1, cKO: n = 4-5/grp/time, cACT: n = 4-6/grp) (#9562 S, Cell Signaling, Danvers, MA, USA). For frozen sections (L6-S1, CC6-CC7) tissues were fixed in 4% paraformaldehyde, decalcified in 14% EDTA for 3 days, infiltrated with 30% sucrose overnight, embedded in OCT, sectioned coronally (10 µm), and stained with DAPI.
Analysis of Histology.
Wnt activity (LacZ expression) quantification within the nucleus pulposus was carried out as previously described 23 . Images of sections were thresholded using ImageJ 1.40 g (National Institutes of Health). The ratio of stained area-to-total area of the nucleus pulposus was normalized to the internal control and used as an outcome. One section was analyzed per IVD. The internal control IVDs were CC10-12 and were not subjected to static compression (Fig. 1B) . Histologically, Wnt activity may appear within and outside of the cell as beta-galactosidase staining is expression of the LacZ transgene 27 . The targeting-efficiency of the Shh-Cre was determined by the percentage of red-fluorescent cells per total DAPI cells. Lastly, the percentage of b-catenin-positive cells per total number of cells in the nucleus pulposus was determined on a 40x magnification image (420 µm × 320 µm).
qRT-PCR. For instrumented animals, tail intervertebral discs between CC7-CC9 and CC10-12 and, for genetic mouse models, tail intervertebral discs CC10-12 and lumbar discs L3-L5 were separated from all other tissues and snap frozen in liquid nitrogen. Then samples were pulverized in a Mikro Dismembrator (B. Braun Biotech International Mikro-Dismembrator S, Germany) and suspended in TRIZOL (Ambion) until further processing. Total RNA extraction was performed using a standard kit (RNeasy mini kit, Qiagen). RNA concentration was quantified (ND-1000, Nanodrop). First strand cDNA was synthesized (iScript, Biorad) from 500 ng of total RNA for Taqman (Life Technologies) 
